The Valley Desk

ArticleHemaSpherePublished

Dual targeting of BCMA and GPRC5D with the trispecific antibody ramantamig addresses antigenic heterogeneity in myeloma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
HemaSphere
Published
PubMed ID
42846987
PubMed Central ID
PMC13644706
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal